Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill
See all our coronavirus coverage
Pfizer has made nearly $26bn (£21bn) in revenues in the first three months of the year, the bulk from its Covid-19 vaccine and new pill to treat the virus, prompting fresh accusations of pandemic profiteering.
Covid vaccines have saved many lives around the world and relieved the pressure on health systems, but Pfizer has faced criticism over its vaccine pricing and its refusal to waive patent protection to enable others to make the jab.
Your consideration of different points of view in this article is impressive.
Great work on this article! Your writing style is engaging and your ideas are presented in a way that is both informative and interesting.
I appreciate the way you challenge conventional wisdom in your writing. It shows a willingness to think critically and consider new ideas.
Your article is very informative and provides practical solutions to the problem. Thank you for sharing your expertise.
Your use of practical tips and advice in your articles makes them actionable and useful.
I think you wrote in a very good and stunning way.
Your article was an interesting read. I never thought of the topic in that way before.
Your article is both informative and inspiring. I appreciate the way you challenge readers to take action and make a difference.